Listed SME IPO INJECTO

Injecto Polymers IPO GMP & Allotment

Injecto Polymers manufactures and trades plastic packaging products, specializing in high-denier fabrics tailored for heavy-duty applications. The company’s core product portfolio encompasses flexible intermediate bulk containers (FIBC), woven sacks, and bags utilized for packaging fertilizers, cement, food grains, and seeds. Operating out of two manufacturing facilities in West Bengal with a combined installed capacity of 10,870 metric tonnes, the business primarily serves customers in eastern India. Injecto Polymers generates revenue through a combination of manufacturing and trading operations, sourcing raw materials like polypropylene granules, high-density polyethylene, and low-density polyethylene from both domestic and international markets. The company caters to the agriculture, construction, textiles, and chemicals sectors, managing its supply chain through a flexible, order-based sales model designed to adapt to fluctuating customer demand and optimize operational scale.

IPO Price Band
₹98.00 - ₹100.00
Lot Size
1,200 Shares
Bidding Closes
16 Sept 2026
Listing Date
21 Sept 2026
Quick Answer & Highlights

Injecto Polymers IPO GMP Today & Key Takeaways

Last updated: 11 Sept 2026

Injecto Polymers IPO officially listed on 21 Sept 2026 at Rs 99.00, delivering a -1.00% listing gain compared to its issue price of Rs 56.12. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.

Injecto Polymers IPO officially listed on 21 Sept 2026 at ₹99.00, delivering a -1.00% listing gain compared to its issue price of ₹56.12. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.

Key Metric Figure Status / Context
Current GMP ₹0 +0% vs upper band (11 Sept 2026)
Est. Listing Price ₹99.00 -1.00% Est. Listing Gain
Price Band ₹98.00 - ₹100.00 SME IPO
Retail Minimum Investment ₹2,40,000 2 Lot (1,200 Shares)
Bidding Window 11 Sept 2026 – 16 Sept 2026 Listed
Allotment & Listing Dates Allotment: 17 Sept 2026 Listing: 21 Sept 2026
Will you apply for this IPO?
Is this GMP accurate?
Did you get allotted this IPO?
IPO Details

Complete IPO information

Injecto Polymers IPO Details and Specifications
IPO Open Date 11 Sept 2026
IPO Close Date 16 Sept 2026
IPO Price Band ₹98.00 - ₹100.00
Lot Size 1,200 Shares
Current GMP ₹0
Estimated Listing Gain -1.00%
Issue Size Approx ₹56.12 Cr
Fresh Issue Approx ₹56.12 Cr
Issue Type SME
IPO Listing BSE SME
Retail Quota TBA
Registrar TBA
Overall Subscription 1.21x
Minimum Investment ₹2,40,000
DRHP Draft Prospectus PDF
RHP Draft Prospectus PDF
Demand Tracker

Subscription Status

Injecto Polymers IPO Subscription Demand Status Breakdown
Category Shares Reserved Shares Applied Subscription (x)
QIB 6.38 9.99 1.57xx
NII 21.49 22.51 1.05xx
Retail 18.67 23.88 1.28xx
Overall Subscription 46.55 56.39 1.21xx
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, Injecto Polymers is priced at ₹100 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,40,000 to participate in this SME issue.

The latest recorded Grey Market Premium for Injecto Polymers stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

As of the latest update, Injecto Polymers's IPO was subscribed 1.21x overall, with a category-wise breakdown of Retail 1.28x, QIB 1.57x, NII 1.05x.

Among the strengths highlighted in Injecto Polymers's IPO documents: Phase IV expansion directly scales core manufacturing capacity.; Debt repayment will improve overall leverage and financial health..

Investors should also weigh the risk factors Injecto Polymers has disclosed, including: Phase IV capital expenditure is subject to execution and cost risks..

A share of Injecto Polymers's issue proceeds is earmarked for Capital Expenditure: 30.5 (54.35%).

SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 11 Sept 2026
✓
Bidding Closes 16 Sept 2026
✓
Allotment 17 Sept 2026
✓
Listing 21 Sept 2026
Injecto Polymers IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 11 Sept 2026 Completed
Bidding Closes 16 Sept 2026 Completed
Allotment 17 Sept 2026 Completed
Listing 21 Sept 2026 Completed
Grey Market Premium

Daily GMP status

Injecto Polymers IPO Daily Grey Market Premium (GMP) Trend & Price History
Date GMP Change Gain
11 Sept 2026 ₹0.00 - TBA
10 Sept 2026 ₹0.00 - 0.00%
Swipe to see more →
Market Lot

Application size breakdown

Injecto Polymers IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 2 Lot 2,400 ₹2,40,000
Retail Maximum 2 Lot 2,400 ₹2,40,000
S-HNI Minimum 3 Lot 3,600 ₹3,60,000
S-HNI Maximum 8 Lot 9,600 ₹9,60,000
B-HNI Minimum 9 Lot 10,800 ₹10,80,000
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

  • Capital Expenditure 30.5 (54.35%)
  • Repayment Of Borrowings 10 (17.82%)
  • General Corporate Purpose 15.62 (27.83%)
Issue Notes

Important takeaways before applying

Strengths

  • Phase IV expansion directly scales core manufacturing capacity.
  • Debt repayment will improve overall leverage and financial health.
  • Strong market foothold across the eastern Indian packaging sector.
  • Proven capability to produce heavy-duty, high-denier fabrics.
  • Solar power infrastructure reduces reliance on the state grid.

Risks

  • Phase IV capital expenditure is subject to execution and cost risks.
  • Restrictive debt covenants currently limit our operational flexibility.
  • Top 5 customers generate over 30% of total operating revenue.
  • Heavy reliance on lower-margin trading activities impacts profits.
  • Negative operating cash flows constrain future working capital.
Analysis

Injecto Polymers IPO Reservation

The Injecto Polymers IPO reservation is divided across anchor investors, qualified institutional buyers, non-institutional investors and retail investors. The NII category has been allocated 33.25% of the offered shares, while retail investors have a 33.27% reservation.

Anchor investors are offered 9,57,600 shares, representing 17.06% of the issue. The QIB category excluding the anchor portion accounts for 11.37%, with 6,38,400 shares offered to this category.

Investor Category Share Offered -% Shares
Anchor Investor 9,57,600 Shares 17.06%
QIB (Ex. Anchor) 6,38,400 Shares 11.37%
NII Shares Offered 18,66,000 Shares 33.25%
Retail Shares Offered 18,67,200 Shares 33.27%

Note: Reservation figures are based on the Injecto Polymers IPO information provided.

Analysis

Injecto Polymers IPO Anchor Investors

Injecto Polymers IPO anchor bidding is scheduled for September 10, 2026, one day before the public issue opens. Anchor investors receive an allocation ahead of the public subscription period, providing an indication of institutional participation in the IPO.

A total of 9,57,600 shares are offered to anchor investors as per the provided details. The anchor allocation is followed by the applicable lock-in periods, with separate restrictions for 50% of the allocated shares for 30 days and the remaining 50% for 90 days.

Particular Details
Anchor Bidding Date September 10, 2026
Shares Offered 9,57,600 Shares
Anchor Size [.] Cr.
Lock-in Period End Date – 50% Shares (30 Days) 2026
Lock-in Period End Date – 50% Shares (90 Days) 2026

Note: Anchor size and lock-in end dates are shown as provided in the Injecto Polymers IPO information.

Analysis

Injecto Polymers IPO Dates

Particular Dates
IPO Open Date 11 Sept 2026
IPO Close Date 16 Sept 2026
Basis of Allotment 17 Sept 2026
Refunds 18 Sept 2026
Credit to Demat Account 18 Sept 2026
IPO Listing Date 21 Sept 2026

Note: The timeline for Injecto Polymers IPO is tentative and subject to change.

Analysis

Injecto Polymers IPO Promoters and Holding Pattern

The promoters of Injecto Polymers are Ramesh Kumar Rateria, Ashok Kumar Rateria, Suman Financial Advisory Pvt.Ltd., Suman Towers Pvt.Ltd., Vinayak Tie-Up Pvt.Ltd., Nivedeeka Commercial Pvt.Ltd. and Bhagyashri Trading Pvt.Ltd. Together, the promoter and promoter group held 88.14% of the company before the IPO.

After the IPO, the promoter and promoter group holding is expected to reduce to 64.35%, while the shareholding of others increases to 35.65%. The total number of outstanding shares rises from 15,177,200 before the IPO to 20,789,600 after the issue.

Particular Pre IPO Shares Pre IPO % Shares Post IPO Shares Post IPO % Shares
Promoter and Promoter Group 13,377,200 88.14% 13,377,200 64.35%
Others* 1,800,000 11.86% 7,412,400 35.65%
Total 15,177,200 100% 20,789,600 100%

Note: The holding pattern is based on the Injecto Polymers IPO shareholding data provided.

Analysis

Injecto Polymers Objects of the Issue & Utilisation of Proceeds

Purpose Crores
Purpose INR crores (%)
Funding Capital expenditure towards setting up phase IV at Unit-I 30.5 (54.35%)
Repayment and/or prepayment of certain borrowings 10 (17.82%)
General corporate purposes 15.62 (27.83%)

Note: Objectives are as specified in the DRHP/RHP documents of Injecto Polymers.

Analysis

Injecto Polymers About Ipo


Since its incorporation in September 1998, Injecto Polymers has been involved in the manufacturing of a wide range of plastic packaging products and the trading of plastic granules and Polyvinyl Chloride (PVC) resins. The firm manufactures a wide range of packaging products, including Polypropylene (PP) Woven Fabrics, PP Woven Bags, Biaxially Oriented Polypropylene (BoPP) Bags, Leno Bags, Low-Density and Polyester Pouches, Flexible Intermediate Bulk Container (FIBC) Bags and Non-Woven Bags. 


Its products are used in various industries such as agriculture, construction, textiles, chemicals, food, pharmaceuticals, cosmetics, and consumer goods. Injecto Polymers operates 2 manufacturing facilities in West Bengal, located at Jaugram, Jamalpur, and Andul Road, Howrah, which are equipped with modern machinery, software-based monitoring systems, and an in-house testing facility. 

Analysis

Injecto Polymers Company Financials

Period Revenue Expense PAT Assets
2024 109.80 Cr. 104.86 Cr. 4.44 Cr. 121.25 Cr.
2025 261.85 Cr. 250.66 Cr. 8.11 Cr. 170.57 Cr.
2026 375.83 Cr. 352.84 Cr. 16.01 Cr. 270.93 Cr.

Note: Financial numbers for Injecto Polymers are in ₹ Crores unless stated otherwise.

Analysis

Injecto Polymers Company Valuation – FY2026

KPI Values
ROE 28.94%
ROCE 15.64%
EBITDA Margin 10.13%
PAT Margin 4.26%
Debt to Equity Ratio –
Earning Per Share (EPS) 10.55 (Basic)
Price/Earning P/E Ratio -
Return on Net Worth (RoNW) 25.28%
Net Asset Value (NAV) 41.73

Note: Valuation KPIs for Injecto Polymers are computed for FY2026.

Analysis

Injecto Polymers IPO Peer Group Comparison

Company EPS PE Ratio RoNW % NAV Income
Emmbi Industries Limited 4.22 19.43 4.06% – 453.99 Cr.
RDB Rasayans Limited 19.17 9.04 13.74% – 143.19 Cr.

Note: Peer group comparisons for Injecto Polymers are sourced from DRHP filings.

Analysis

Injecto Polymers IPO Lead Managers aka Merchant Bankers

  • Indcap Advisors Pvt. Ltd.
Comparison

Compare Injecto Polymers IPO with similar IPOs

FAQ

Injecto Polymers IPO FAQs

Injecto Polymers IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Injecto Polymers IPO price band is Rs 98.00 to Rs 100.00. Check the latest issue price, lot size and GMP together before applying.
Injecto Polymers IPO open date is 11 Sept 2026, close date is 16 Sept 2026, and listing date is 21 Sept 2026.
Injecto Polymers IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,40,000.
Injecto Polymers is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Injecto Polymers IPO subscription status currently shows Retail 1.28x, QIB 1.57x, NII 1.05x, Overall 1.21x.
Injecto Polymers manufactures and trades plastic packaging products, specializing in high-denier fabrics tailored for heavy-duty applications. The company’s core product portfolio encompasses flexible intermediate bulk containers (FIBC), woven sacks, and bags utilized for packaging fertilizers, cement, food grains, and seeds. Operating out of two manufacturing facilities in West Bengal with a combined installed capacity of 10,870 metric tonnes, the business primarily serves customers in eastern India. Injecto Polymers generates revenue through a combination of manufacturing and trading operations, sourcing raw materials like polypropylene granules, high-density polyethylene, and low-density polyethylene from both domestic and international markets. The company caters to the agriculture, construction, textiles, and chemicals sectors, managing its supply chain through a flexible, order-based sales model designed to adapt to fluctuating customer demand and optimize operational scale.
Injecto Polymers IPO issue size is 56.12 and the expected allotment date is 17 Sept 2026.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Injecto Polymers.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Injecto Polymers IPOInjecto Polymers GMPInjecto Polymers IPO GMPInjecto Polymers IPO GMP todayInjecto Polymers grey market premiumInjecto Polymers price bandInjecto Polymers subscription statusInjecto Polymers allotment statusInjecto Polymers listing dateInjecto Polymers lot sizeInjecto Polymers IPO reviewInjecto Polymers IPO listing gain estimateInjecto Polymers GMP calculatorInjecto Polymers IPO 2026